Top

Skeletal Radiology

Published in:

01-05-2016 | Scientific Article

Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures

Authors: Jennifer L. Favinger, Daniel Hippe, Alice S. Ha

Published in: Skeletal Radiology | Issue 5/2016

Abstract

Objective

To evaluate the appearance of bisphosphonate-related femur insufficiency fractures on long-term follow-up radiographic studies and to describe the rate of fracture line obscuration and cortical beak healing over time.

Materials and methods

In this retrospective study, bisphosphonate-related femur fracture radiographs were reviewed by two radiologists for the presence of a fracture line, callus, and the characteristic cortical beak. Kaplan–Meier curves were used to analyze the time to first indication of healing. Femurs were also subdivided into those who underwent early versus late surgical fixation and those who underwent early versus late discontinuation of bisphosphonate. Clinical data including pain level and medication history were collected.

Results

Forty-seven femurs with a bisphosphonate-related femur fracture were identified in 28 women. Eighty-five percent took a bisphosphonate for greater than 5 years and 59 % for greater than 10 years. The median time to beak healing was 265 weeks and the median time to fracture line healing was 56 weeks in the 31 femurs with a baseline fracture. No statistically significant difference was identified between surgical fixation and conservative management.

Conclusions

Bisphosphonate-related fractures demonstrate notably prolonged healing time on long-term follow-up.

Einhorn TA, Bogdan Y, Tornetta P. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment. J Orthop Trauma. 2014;28(7):433–8.CrossRefPubMed

Park-Wyllie LY, Mamdani MM, Juurlink DN, et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011;305(8):783–9.CrossRefPubMed

Porrino Jr JA, Kohl CA, Taljanovic M, Rogers LF. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. Am J Roentgenol. 2010;194:1061–4.CrossRef

Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systemic review and meta-analysis. J Bone Miner Res. 2013;28(8):1729–37.CrossRefPubMedPubMedCentral

Khan SA, Kanis JA, Vasikaran S, et al. Elimination and biochemical response to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res. 1997;12(10):1700–7.CrossRefPubMed

Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during and after bisphosphonate use: full report of a nationwide study. Acta Orthop. 2015;86(1):100–7.CrossRefPubMedPubMedCentral

Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014;371(10):974–6.CrossRefPubMed

Turnbull BW. Nonparametric estimation of a survivorship function with doubly censored data. J Am Stat. 1974;69(345):169–73.CrossRef

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. Hoboken: John Wiley & Sons; 2011.

10.

Diggle P, Heagerty P, Liang K-Y, Zeger S. Analysis of longitudinal data. Oxford: University Press; 2002. 396 pp.

11.

Dijkman BG, Sprague S, Schemitsch EH, Bhandari M. When is a fracture healed? Radiographic and clinical criteria revisited. J Orthop Trauma. 2010;24 Suppl 1:S76–80.CrossRefPubMed

12.

Corrales LA, Morshed S, Bhandari M, Miclau T. Variability in assessment of fracture-healing in orthopedic trauma studies. J Bone Joint Surg Am. 2008;90(9):1862–8.CrossRefPubMedPubMedCentral

13.

Browner BD, Jupiter JB, Levin AM, Trafton PG, Krettek C. Skeletal trauma: basic science, management and reconstruction. Philadelphia: Saunders Elsevier; 2009.

14.

Nikolaou VS, Efstathopoulos N, Kontakis G, Kanakaris NK, Giannoudis PV. The influence of osteoporosis in femoral fracture healing time. Injury. 2009;40(6):663–8.CrossRefPubMed

15.

Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011;42(6):551–5.CrossRefPubMedPubMedCentral

16.

Vigorita VJ, Silver JS, Eisemon EO. Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report. Skelet Radiol. 2012;41(7):861–5.CrossRef

17.

Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015;26:1251–60.CrossRefPubMed

18.

Banffy MB, Vrahas MS, Ready JE, Abraham JA. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures. Clin Orthop Relat Res. 2011;469(7):2028–34.CrossRefPubMedPubMedCentral

19.

Egol KA, Park JH, Prensky C, Rosenberg ZS, Peck V, Tejwani NC. Surgical treatment improves clinical and functional outcomes for patients who sustain incomplete bisphosphonate-related femur fractures. J Orthop Trauma. 2013;27(6):331–5.CrossRefPubMed

20.

Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res. 2014;472(9):2728–34.CrossRefPubMedPubMedCentral

21.

Miyakoshi N, Aizawa T, Saski S, et al. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab. 2015;33(5):553–9.CrossRefPubMed

22.

Zhang D, Potty A, Vyas P, Lane J. The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma. 2014;28(1):57–62.CrossRefPubMed

23.

Chiang CY, Zebaze RMD, Ghasem-Zadeh A, et al. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone. 2013;52(1):360–5.CrossRefPubMed

Title: Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures
Authors: Jennifer L. Favinger
Daniel Hippe
Alice S. Ha
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Skeletal Radiology / Issue 5/2016
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI: https://doi.org/10.1007/s00256-016-2346-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures

Abstract

Objective

Materials and methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2016

Successful conservative management of symptomatic bilateral dorsal patellar defects presenting with cartilage involvement and bone marrow edema: MRI findings

MRI and clinical features of Langerhans cell histiocytosis (LCH) in the pelvis and extremities: can LCH really look like anything?

MRI findings associated with development of incident knee pain over 48 months: data from the osteoarthritis initiative

Erratum to: The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography

Sarcoidosis: radiographic manifestations in the nails and distal phalanges

The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography